
Black Rose Indus Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Acrylamide solid export volumes expected to increase this quarter due to new customer acquisition and better product acceptance despite global market disruptions (Page 17).
- Polyacrylamide liquid sales affected by subdued demand in Morbi tile industry but new R&D efforts on improved binders and dispersants aim to boost revenue and product mix (Page 5).
- NMA (N-Methyl Acetoacetamide) commercial sales started with a large customer, expected to raise revenue and profit substantially (Page 5).
- Distribution business anticipates substantial volume and revenue growth supported by stable domestic demand, improved supply from principals, and expected export volume pick-up after US demand revival (Page 4).
- Manufacturing volumes largely flat quarter-to-quarter, but 9 months show slight growth with expectation to surpass previous fiscal year volumes (Page 15).
- At full capacity and current market conditions, manufacturing revenue potential estimated between ₹300 to ₹400 crores (Page 14).
- Overall focus remains on maximizing sales, revenue, and profitability aligned with competitive pricing and cost efficiencies (Pages 14-17).
See what Black Rose Indus management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Black Rose Indus management said on order book — free account, 30 seconds.
Capex plans
Yes- Black Rose Industries is planning a polyacrylamide solid plant requiring an investment between ₹60 to ₹100 crore, depending on the technology chosen (domestic or imported).
- The company is in advanced discussions for a specialty chemicals project at the Jhagadia site in collaboration with a Japanese principal.
- Talks are underway for two toll manufacturing projects related to acrylamide chemistry with companies from Europe and the US.
- The company is also seeking to acquire about 20 acres of new land for future projects and expansion requirements.
- Fund-raising for these investments will be considered at the appropriate time after finalizing the technology and project details.
- Current capital expenditure on existing capacity setups (like NMA and acrylamide solid) has been very low, benefiting from low CapEx structures.
Track Black Rose Indus — get its next earnings analysis in your feed
How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Black Rose Indus rank in Chemicals & Petrochemicals?
Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Black Rose Indus's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…